Product Information
AZITHROMYCIN 200 MG/5 ML SUSP is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.3247 per ML under NDC 70436022134. Its NADAC has been published 81 times since Nov 6, 2024.
FDA first approved this application on Jul 27, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/5mL
Manufacturer
Slate Run Pharmaceuticals LLCNDC
70436022134
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
AZITHROMYCIN DIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA217036FDA Approved
7/27/2023
TE Code
AB
On Market Since
1/1/2024
Pharmacological Classes
Price Statistics
The NADAC for AZITHROMYCIN 200 MG/5 ML SUSP has been published 81 times since Nov 6, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3247 per ML |
|---|---|
| All-time high | $0.3502 (Sep 10, 2025) |
| All-time low | $0.2722 (Nov 20, 2024) |
| 52-week high | $0.3502 |
| 52-week low | $0.3128 |
| Median price | $0.3301 |
| Average price | $0.3242 |
| Largest weekly change | -16.9% (Nov 20, 2024) |
| Weeks tracked | 81 |
| Tracking since | Nov 6, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
+2.6%
1Y
-7.3%
3Y
N/A
5Y
N/A
All
-0.9%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AZITHROMYCIN 200 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for AZITHROMYCIN 200 MG/5 ML SUSP, manufactured by Slate Run Pharmaceuticals LLC, is $0.3247 per ML (NDC 70436022134), effective May 20, 2026.
How has the price of AZITHROMYCIN 200 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for AZITHROMYCIN 200 MG/5 ML SUSP has held within roughly two percent of its current level. It has been tracked across 81 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for AZITHROMYCIN 200 MG/5 ML SUSP?
Since Nov 6, 2024, the NADAC for AZITHROMYCIN 200 MG/5 ML SUSP has ranged from a low of $0.2722 (Nov 20, 2024) to a high of $0.3502 (Sep 10, 2025), with a median of $0.3301 per ML.
Are there cheaper alternatives to AZITHROMYCIN 200 MG/5 ML SUSP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AZITHROMYCIN 200 MG/5 ML SUSP, is $0.2186 per ML — about 33% below AZITHROMYCIN 200 MG/5 ML SUSP.
Who manufactures AZITHROMYCIN 200 MG/5 ML SUSP?
AZITHROMYCIN 200 MG/5 ML SUSP (NDC 70436022134) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.